Metropolis Healthcare Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Surendran Chemmenkotil
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.9yrs |
| CEO ownership | n/a |
| Management average tenure | 1.1yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 13
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 14Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next
May 24Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | n/a | n/a | ₹1b |
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹1b |
| Mar 31 2023 | ₹52m | ₹13m | ₹1b |
Compensation vs Market: Insufficient data to establish whether Surendran's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Insufficient data to compare Surendran's compensation with company performance.
CEO
Surendran Chemmenkotil
1.9yrs
Tenure
₹52,318,552
Compensation
Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairperson | 16.6yrs | ₹47.88m | 0.35% ₹ 374.2m | |
| Founder & Chairman Emeritus | no data | ₹18.00m | 18.44% ₹ 19.5b | |
| Chief Executive Officer | 1.9yrs | ₹52.32m | no data | |
| Interim Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Chief Scientific & Innovation Officer | no data | no data | no data | |
| Chief Information Officer | less than a year | no data | no data | |
| Head of Legal & Secretarial and Compliance Officer | less than a year | no data | no data | |
| Head of Public Relations & Corporate Communications | 3.3yrs | no data | no data | |
| Chief Marketing Officer | 1.3yrs | no data | no data | |
| Chief People Officer | 4.9yrs | no data | no data | |
| President of Internal Assurance & Advisor to CEO | no data | no data | no data |
1.1yrs
Average Tenure
45yo
Average Age
Experienced Management: METROPOLIS's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairperson | 16.6yrs | ₹47.88m | 0.35% ₹ 374.2m | |
| Founder & Chairman Emeritus | 19.3yrs | ₹18.00m | 18.44% ₹ 19.5b | |
| Non-Executive Independent Director | 4.6yrs | ₹2.18m | no data | |
| Non-Executive Independent Director | 6.3yrs | ₹1.73m | no data | |
| Non-Executive Independent Director | 6.3yrs | ₹1.85m | 0.00028% ₹ 295.4k | |
| Independent Director | less than a year | ₹500.00k | no data | |
| Non-Executive Independent Director | 3.6yrs | no data | no data | |
| Non-Executive Director | less than a year | no data | no data |
5.4yrs
Average Tenure
58.5yo
Average Age
Experienced Board: METROPOLIS's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 21:59 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Metropolis Healthcare Limited is covered by 33 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Prashant Nair | Ambit Capital |
| null null | Antique Stockbroking Ltd. |
| Harith Ahamed | Avendus Spark |